tirzepatide lancet for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Tirzepatide weight loss maintenance study

For patients with thyroid disease, this test helps identify which GLP-1 compound and concentration are most likely to succeed, complementing your thyroid monitoring and personalizing your pathway to sustained weight loss

Sukenik S: Balneotherapy for rheumatic diseases at the Dead Sea area

Dare to compare with other leading brands in the market

Eli Lilly followed Novo Nordisk with the GLP-1 receptor agonists for weight loss, as their medicine, Mounjaro, was approved for weight loss in the UK in November 2023

Berberine is a plant alkaloid found in herbs like goldenseal, Oregon grape, and barberry

Food and Drug Administration (FDA) to reduce heart risks, could end up increasing healthcare costs by billions of dollars, according to new research published in Annals of Internal Medicine .[1] Semaglutide is a GLP-1 receptor agonist originally developed to treat diabetes